Roche (OTCMKTS:RHHBY) Now Covered by Morgan Stanley

Stock analysts at Morgan Stanley began coverage on shares of Roche (OTCMKTS:RHHBY) in a report issued on Wednesday, Marketbeat reports. The brokerage set an “equal weight” rating on the stock.

Separately, Sanford C. Bernstein upgraded shares of Roche to a “strong-buy” rating in a report on Thursday, January 30th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Roche Stock Up 2.6 %

Shares of OTCMKTS RHHBY opened at $41.29 on Wednesday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. Roche has a one year low of $29.20 and a one year high of $42.43. The business has a 50-day moving average price of $36.85 and a two-hundred day moving average price of $38.31.

Institutional Investors Weigh In On Roche

Several large investors have recently made changes to their positions in the company. Bard Financial Services Inc. raised its stake in shares of Roche by 37.7% in the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after acquiring an additional 30,350 shares in the last quarter. Diversified Trust Co grew its holdings in Roche by 1.2% during the fourth quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock valued at $2,130,000 after purchasing an additional 711 shares during the last quarter. Hantz Financial Services Inc. raised its position in shares of Roche by 0.9% in the fourth quarter. Hantz Financial Services Inc. now owns 33,708 shares of the company’s stock valued at $1,176,000 after purchasing an additional 305 shares during the period. Brooklyn Investment Group lifted its stake in shares of Roche by 36.6% in the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after buying an additional 363 shares during the last quarter. Finally, Canopy Partners LLC boosted its holdings in shares of Roche by 4.6% during the 3rd quarter. Canopy Partners LLC now owns 7,772 shares of the company’s stock worth $310,000 after buying an additional 344 shares during the period.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.